Anti-SYP monoclonal antibody

Pre-made anti-SYP monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SYP/SYP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1872-Ab-1/ GM-Tg-hg-IP1872-Ab-2Anti-Human SYP monoclonal antibodyHuman
GM-Tg-rg-IP1872-Ab-1/ GM-Tg-rg-IP1872-Ab-2Anti-Rat SYP monoclonal antibodyRat
GM-Tg-mg-IP1872-Ab-1/ GM-Tg-mg-IP1872-Ab-2Anti-Mouse SYP monoclonal antibodyMouse
GM-Tg-cynog-IP1872-Ab-1/ GM-Tg-cynog-IP1872-Ab-2Anti-Cynomolgus/ Rhesus macaque SYP monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1872-Ab-1/ GM-Tg-felg-IP1872-Ab-2Anti-Feline SYP monoclonal antibodyFeline
GM-Tg-cang-IP1872-Ab-1/ GM-Tg-cang-IP1872-Ab-2Anti-Canine SYP monoclonal antibodyCanine
GM-Tg-bovg-IP1872-Ab-1/ GM-Tg-bovg-IP1872-Ab-2Anti-Bovine SYP monoclonal antibodyBovine
GM-Tg-equg-IP1872-Ab-1/ GM-Tg-equg-IP1872-Ab-2Anti-Equine SYP monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1872-Ab-1/ GM-Tg-hg-IP1872-Ab-2; GM-Tg-rg-IP1872-Ab-1/ GM-Tg-rg-IP1872-Ab-2;
GM-Tg-mg-IP1872-Ab-1/ GM-Tg-mg-IP1872-Ab-2; GM-Tg-cynog-IP1872-Ab-1/ GM-Tg-cynog-IP1872-Ab-2;
GM-Tg-felg-IP1872-Ab-1/ GM-Tg-felg-IP1872-Ab-2; GM-Tg-cang-IP1872-Ab-1/ GM-Tg-cang-IP1872-Ab-2;
GM-Tg-bovg-IP1872-Ab-1/ GM-Tg-bovg-IP1872-Ab-2; GM-Tg-equg-IP1872-Ab-1/ GM-Tg-equg-IP1872-Ab-2
Products NameAnti-SYP monoclonal antibody
Formatmab
Target NameSYP
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SYP monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1872-Ag-1Recombinant multi-species SYPH/ SYP/ MRX96 protein
    ORF Viral VectorvGMLP003530human SYP Lentivirus particle
    ORF Viral VectorpGMLP003530human SYP Lentivirus plasmid


    Target information

    Target IDGM-IP1872
    Target NameSYP
    Gene ID6855,20977,24804,715739,612557,101084343,280937,100062804
    Gene Symbol and SynonymsA230093K24Rik,MRX96,MRXSYP,p38,Syn,SYP,Syp1,XLID96
    Uniprot AccessionP08247,P07825,P20488
    Uniprot Entry NameSYPH_HUMAN,SYPH_RAT,SYPH_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseDesmoplastic small round cell tumor (DSRCT), Schizophrenia
    Gene EnsemblENSG00000102003
    Target ClassificationN/A

    The target: SYP, gene name: SYP, also named as MRX96, MRXSYP. This gene encodes an integral membrane protein of small synaptic vesicles in brain and endocrine cells. The protein also binds cholesterol and is thought to direct targeting of vesicle-associated membrane protein 2 (synaptobrevin) to intracellular compartments. Mutations in this gene are associated with an X-linked form of cognitive disability. [provided by RefSeq, Jul 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.